Bern2019WDP data

The study “Continuous recording of vital signs with a wearable device in pediatric patients undergoing chemotherapy for cancer – an operational feasibility study” (NCT04134429) recruited patients from November 2019 to January 2020 in a single center, the Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Nine different vital signs and health indicators, plus quality scores to six of them, were recorded by the wearable device (WD) Everion® during a total of 274 days (6576 hours) in 20 patients (study period of 14 days each patient). This resulted in 85’854 measuring points, which are a total of 772’686 measurements of vital signs and health indicators, plus 515’124 quality scores. Additionally, non-WD data like side effects, acceptability and usability, reasons not to wear the WD, and effort for the investigators was collected. 20 files, one per patient, contain the WD data e.g. the vital signs and their quality score recorded by the WD. A Readme file explains all the variables. One file contains the non-WD data of all 20 patients on administration, follow-up and outcomes of the daily CRF. Another Readme file explains all the variables.

本研究《癌症化疗患儿佩戴可穿戴设备持续监测生命体征：一项操作性可行性研究》（临床试验注册号：NCT04134429）于2019年11月至2020年1月间，在单中心——瑞士伯尔尼市伯尔尼大学附属医院因塞尔医院（Inselspital）儿科部招募受试者。研究共纳入20例癌症化疗患儿，每位受试者的研究周期为14天；使用Everion®可穿戴设备（wearable device, WD）连续采集了总计274天（6576小时）的9项生命体征与健康指标数据，并为其中6项指标配套了质量评分。最终共得到85854个测量节点，累计完成772686次生命体征与健康指标测量，以及515124项质量评分。此外，研究团队还收集了非可穿戴设备相关数据，包括不良反应发生情况、设备可接受性与易用性、未佩戴设备的原因，以及研究人员的工作量等信息。本次数据集包含20份患者专属数据文件，每份文件对应1例受试者，存储由Everion®可穿戴设备采集的生命体征及其配套质量评分等WD相关数据；配套的一份说明文件（Readme）将对所有变量进行详细阐释。另有1份汇总文件，涵盖全部20例受试者的非WD相关数据，包括每日病例报告表（Case Report Form, CRF）中的给药情况、随访信息与结局指标；另有一份说明文件（Readme）对该汇总文件的所有变量进行解释。